KN · NYSE · Technology
Knowles Corporation (KN) — Rank #281 by gross profitability (GP/assets 0.24) · ROE 5.7% · Piotroski F-Score N/A.
As-of 2026-10-30 · CIK 0001587523 · all metrics point-in-time as of the filing date.
About
Knowles Corporation offers capacitors, radio frequency (RF) and microwave filters, balanced armature speakers, and medtech microphones in Asia, the United States, Europe, rest of Americas, and internationally.
Show moreShow less
It operates in two segments, Precision Devices (PD) and Medtech & Specialty Audio (MSA). The PD segment focuses on the custom design and delivery of high performance capacitor products and RF solutions primarily serving the defense, industrial, medtech, and electrification/energy markets. The MSA segment designs and manufactures balanced armature speakers and microphones for the hearing health; and specialty audio applications that serve the medtech and industrial markets. The company manufactures and sells film, electrolytic, and mica capacitors that are used in medtech, defense, and industrial electrification applications. It serves the defense, medtech, electric vehicle, industrial, and communications markets through original equipment manufacturers, their contract manufacturers, suppliers, sales representatives, and distributors.
Knowles Corporation was founded in 1946 and is headquartered in Itasca, Illinois.
- Industry
- Electronic Components
- Sector
- Technology
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
- Website
- knowles.com
Company Snapshot
P/E and reverse DCF are the primary valuation lenses at this stage.
Market Cap
—
P/E (annual)
—
P/S (annual)
—
P/B
—
P/OCF (annual)
—
Shareholder Yield
—
Employees
5,200
Industry
Electronic Components
Exchange
NYSE
10/10
Flags passed
KN passes 10/10 quality flags
- PASSGross margin holding
- PASSDilution within 2%
- PASSDisclosure consistent
- PASSRevenue not declining
- PASSOperating margin holding
- PASSPasses safety gate
- PASSBalance sheet stable
- PASSNo competitive retreat
- PASSSBC not compressing margin
- PASSNo valuation convergence
Strengths Operating leverage expanding
No data FCF vs investment · Free cash flow — not counted as a pass.
A count of the 12 warning flags that could be evaluated. Unweighted: colour follows the worst flag.
Quality Profile
Profitability
1/1 passSafety
1/1 passCash Flow
Growth
2/2 passFCF yield, shareholder yield, and buyback activity are the primary reads at this stage.
Profitability
Does it make money well?
No warning flags · GP/assets 43rd percentile of 47 SIC 36 peers
Gross profitability (GP / assets)
0.24
Primary signal (Novy-Marx).
43rd pctl of 47 SIC 36 peers
Return on equity
5.7%
Gross margin
43.2%
50th pctl of 47 SIC 36 peers
Revenue growth (YoY)
7.2%
Gross margin improving
Margin trend vs prior year.
Operating Leverage
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue vs COGS | ||||
| Revenue vs OpEx | ||||
| Op. Income vs Revenue |
Growth
Revenue CAGR (3Y)
7.4%
Revenue CAGR (5Y)
-4.9%
Earnings CAGR (3Y)
—
FCF CAGR (3Y)
—
Cash Flow Health
Is the cash real?
No data
Free cash flow
—
Operating cash flow minus capex.
Positive free cash flow
FCF vs net income
—
(FCF − net income) ÷ |net income|. Positive: cash above earnings. Negative: below.
FCF not below net income
Fails when free cash flow is below net income (yellow flag).
Accruals healthy
Cash-backed earnings.
SBC / revenue
4.8%
Stock-based comp intensity.
Balance Sheet Strength
Can it survive a storm?
No warning flags · net debt $79.30M
Balance-sheet safety
Composite anti-fragile check.
Debt / equity
0.35
73rd pctl of 45 SIC 36 peers (best = lowest)
Current ratio
3.27×
63rd pctl of 47 SIC 36 peers
Quick ratio
1.65×
Net cash
-$79.30M
Cash & equivalents minus total debt.
Piotroski F-Score
N/A
Only 7/9 components determinable.
Valuation
Is the price reasonable?
No warning flags
Capital allocation quality
Composite score
3.3 / 5
Lifecycle Phase History
Price History
Source filings on SEC EDGAR: 10-K annual reports · 10-Q quarterly reports